FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Hutson

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Toni K Choueiri; Mario A Eisenberger; Noah M Hahn; Thomas E Hutson; Susanna Jacobus; Glenn J Bubley; Geoffrey C Buckle; William Y Kim; Stephanie C Morrissey; Amir Mortazavi; Daniel P Petrylak; David I Quinn; Jonathan E Rosenberg; Robert W Ross; Christopher W Ryan; Guru Sonpavde; Mary-Ellen Taplin; Ulka Nitin Vaishampayan; Evan Y Yu; Philip W Kantoff
Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Brian I Rini; Brad Rosbrook; Igor G Rusakov; Cezary Szczylik; Jamal Tarazi; Piotr Tomczak; Hirotsugu Uemura; Sylvie Negrier; Yen-Chuan Ou; Daniel Castellano; David Cella; Connie Chen; Bernard Escudier; Vera A Gorbunova; Martin E Gore; Thomas E Hutson; Andrey Kaprin; Sinil Kim; Ho Yeong Lim; M Dror Michaelson; Robert J Motzer
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Jorge A Garcia; Thomas E Hutson; Dale Shepard; Paul Elson; Robert Dreicer
Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Hutson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Toni K Choueiri; Mario A Eisenberger; Noah M Hahn; Thomas E Hutson; Susanna Jacobus; Glenn J Bubley; Geoffrey C Buckle; William Y Kim; Stephanie C Morrissey; Amir Mortazavi; Daniel P Petrylak; David I Quinn; Jonathan E Rosenberg; Robert W Ross; Christopher W Ryan; Guru Sonpavde; Mary-Ellen Taplin; Ulka Nitin Vaishampayan; Evan Y Yu; Philip W Kantoff
Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(5):507-12.
2011: Brian I Rini; Brad Rosbrook; Igor G Rusakov; Cezary Szczylik; Jamal Tarazi; Piotr Tomczak; Hirotsugu Uemura; Sylvie Negrier; Yen-Chuan Ou; Daniel Castellano; David Cella; Connie Chen; Bernard Escudier; Vera A Gorbunova; Martin E Gore; Thomas E Hutson; Andrey Kaprin; Sinil Kim; Ho Yeong Lim; M Dror Michaelson; Robert J Motzer
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Lancet 2011;378(9807):1931-9.
2011: Jorge A Garcia; Thomas E Hutson; Dale Shepard; Paul Elson; Robert Dreicer
Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.
Cancer 2011;117(4):752-7.
2010: Ivan N Zama; Thomas E Hutson; Paul Elson; James M Cleary; Toni K Choueiri; Daniel Y C Heng; Nikhil Ramaiya; M Dror Michaelson; Jorge A Garcia; Jennifer J Knox; Bernard Escudier; Brian I Rini
Sunitinib rechallenge in metastatic renal cell carcinoma patients.
Cancer 2010;116(23):5400-6.
2010: Jorge A Garcia; Thomas E Hutson; Paul Elson; C Lance Cowey; Timothy Gilligan; Cheryl Nemec; Robert Dreicer; Ronald M Bukowski; Brian I Rini
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab.
Cancer 2010;116(23):5383-90.
2008: Brian I Rini; M Dror Michaelson; Jonathan E Rosenberg; Ronald M Bukowski; Jeffrey A Sosman; Walter M Stadler; Thomas E Hutson; Kim Margolin; Charles S Harmon; Samuel E DePrimo; Sindy T Kim; Isan Chen; Daniel J George
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3743-8.
2008: Saby George; Thomas E Hutson; Tarek Mekhail; Laura Wood; James Finke; Paul Elson; Robert Dreicer; Ronald M Bukowski
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
Cancer chemotherapy and pharmacology 2008;62(2):347-54.
2007: Ena Segota; Tarek Mekhail; Thomas Olencki; Thomas E Hutson; Robert Dreicer; Brenda Wacker; Bruno Osterwalder; Paul Elson; Ming Zhou; Ronald M Bukowski
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity.
Urologic oncology 2007;25(1):46-52.
2006: Toni K Choueiri; Tarek Mekhail; Thomas E Hutson; Ram Ganapathi; G E Kelly; Ronald M Bukowski
Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):860-5.
2004: Adrian G Grozav; Thomas E Hutson; Xiang Zhou; Ronald M Bukowski; Ram Ganapathi; Yan Xu
Rapid analysis of docetaxel in human plasma by tandem mass spectrometry with on-line sample extraction.
Journal of pharmaceutical and biomedical analysis 2004;36(1):125-31.
2004: Thomas E Hutson; Ram Ganapathi; Paul Elson; Tarek Mekhail; Thomas Olencki; G Thomas Budd; Ronald M Bukowski
Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.
Investigational new drugs 2004;22(3):277-84.
2004: Gheath Alatrash; Thomas E Hutson; Luis Molto; Amy L Richmond; Cheryl Nemec; Tarek Mekhail; Paul Elson; Charles S Tannenbaum; Thomas Olencki; James Finke; Ronald M Bukowski
Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2891-900.
2003: Toni K Choueiri; Thomas E Hutson; Ronald M Bukowski
Evolving role of pegylated interferons in metastatic renal cell carcinoma.
Expert review of anticancer therapy 2003;3(6):823-9.
2003: Thomas E Hutson; Luis Molto; Tarek Mekhail; Paul Elson; James Finke; Charles S Tannenbaum; Ernest C Borden; Robert Dreicer; Thomas Olencki; Ronald M Bukowski
Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1354-60.
2003: Tarek Mekhail; Thomas E Hutson; Paul Elson; G Thomas Budd; Gordan Srkalovic; Thomas Olencki; David M Peereboom; Robert Pelley; Ronald M Bukowski
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.
Cancer 2003;97(1):170-8.